| ARVN | CLUSTER | bearish | 5/10 | Three top executives at Arvinas, including the CEO, Chief Scientific Officer, and Chief Accounting Officer, each sold ap | Feb 26, 2026 |
| TWST | CLUSTER | bearish | 7/10 | Four corporate insiders at Twist Bioscience Corp, including the CEO, COO, CFO, and another executive, sold shares in a c | Feb 26, 2026 |
| VERA | CLUSTER | bearish | 8/10 | Seven executives at Vera Therapeutics, including the CEO, CFO, and other C-suite officers, collectively sold over $1.4 m | Feb 26, 2026 |
| OCUL | CLUSTER | mixed | 6/10 | A cluster of insider transactions at Ocular Therapeutix (OCUL) over the past week shows mixed activity: one significant | Feb 26, 2026 |
| CGEM | CLUSTER | bearish | 6/10 | Five insider trades occurred at Cullinan Therapeutics (CGEM) over the past seven days, all involving open-market sales b | Feb 26, 2026 |
| VERA | CLUSTER | bearish | 5/10 | Seven executives at Vera Therapeutics, including the CEO and CFO, collectively sold over $1.4 million in shares on Febru | Feb 25, 2026 |
| VERA | CLUSTER | bearish | 7/10 | Five executive officers at Vera Therapeutics, including the CEO and CFO, collectively sold over $1.2 million in shares i | Feb 25, 2026 |
| VERA | CLUSTER | bearish | 7/10 | Four C-suite executives at Vera Therapeutics, including CEO Fordyce Marshall, sold shares in a coordinated open-market t | Feb 25, 2026 |
| VERA | CLUSTER | bearish | 6/10 | Three senior executives at Vera Therapeutics, the Chief Regulatory Officer, Chief Operating Officer, and Chief Commercia | Feb 25, 2026 |
| VERA | CLUSTER | bearish | 5/10 | Two C-suite executives at Vera Therapeutics, the Chief Regulatory Officer and Chief Commercial Officer, sold shares in a | Feb 25, 2026 |
| IRWD | CLUSTER | bearish | 7/10 | Ironwood Pharmaceuticals CEO Thomas McCourt and CFO Gregory Martini collectively sold over $821,000 worth of shares in o | Feb 25, 2026 |
| TWST | CLUSTER | bearish | 6/10 | Three insiders at Twist Bioscience Corp sold shares in a coordinated open-market transaction on February 23, 2026, inclu | Feb 25, 2026 |
| KALV | CLUSTER | bearish | 6/10 | Seven executives at KalVista Pharmaceuticals, including the CEO, CFO, CMO, CDO, and CCO, exercised stock options and sol | Feb 25, 2026 |
| CRBU | CLUSTER, CLUSTER | neutral | 4/10 | Multiple C-suite executives at Caribou Biosciences (CRBU) sold shares in a coordinated cluster over a 7-day window, tota | Feb 24, 2026 |
| CRBU | CLUSTER | neutral | 3/10 | Two C-suite executives at Caribou Biosciences, the Chief Business Officer and Chief Medical Officer, sold shares worth a | Feb 24, 2026 |
| KALV | CLUSTER, CLUSTER | bearish | 7/10 | Multiple C-suite executives at KalVista Pharmaceuticals (KALV) sold shares in a coordinated cluster over the past week, | Feb 24, 2026 |
| KALV | CLUSTER | bearish | 6/10 | Multiple C-suite executives at KalVista Pharmaceuticals (KALV) sold shares in a concentrated 7-day window, including the | Feb 24, 2026 |
| KALV | CLUSTER | neutral | 4/10 | Two C-suite executives at KalVista Pharmaceuticals, the CFO and Chief Commercial Officer, sold shares worth $89,385 in t | Feb 24, 2026 |
| VIR | CLUSTER | neutral | 4/10 | Multiple top executives at Vir Biotechnology, including the CEO, CFO, and CMO, sold shares worth over $220K in the past | Feb 24, 2026 |
| VIR | CLUSTER | neutral | 4/10 | Multiple top executives at Vir Biotechnology, including the CEO, CFO, and Chief Medical Officer, sold shares in a coordi | Feb 24, 2026 |
| VIR | CLUSTER | bearish | 6/10 | Multiple C-suite executives at Vir Biotechnology, including the CEO, CMO, and General Counsel, sold shares worth over $1 | Feb 24, 2026 |
| VIR | CLUSTER | neutral | 4/10 | CEO Marianne De Backer and EVP Vanina de Verneuil sold significant shares in Vir Biotechnology, totaling $175K in procee | Feb 24, 2026 |
